Abstract. Apathy and depression are the most frequent neuropsychiatric symptoms in Alzheimer's disease (AD). In a crosssectional observational study of 734 subjects with probable mild AD, we evaluated the prevalence of apathy and depression. After the use of specific diagnostic criteria, we tested the interaction between the two syndromes and their relation with specific comorbidities, and different functional outcomes. Depression was diagnosed using the diagnostic criteria for depression in AD, and apathy with the diagnostic criteria for apathy in neuropsychiatric disorders. According to the specific diagnostic criteria, depression had a 47.9% prevalence, while apathy prevalence was 41.6%. Apathy and depression were associated in 32.4% of patients (n = 225). 9.4% (n = 65) had only apathy, 15.4% (n = 107) had only depression, and 42.9% had no apathy and no depression (n = 298). The three most frequent depressive symptoms were fatigue or loss of energy (59.4%), decreased positive affect or pleasure in response to social contacts and activities (46.2%), and psychomotor agitation or retardation (36.9%). Concerning apathy, loss of goal-directed cognition was the most frequently altered (63.6%), followed by loss of goal-directed action (60.6%) and loss of goal-directed emotion (43.8%). Patients with both apathy and depression more frequently required a resource allowance for dependency. Neurological comorbidities were more frequent in the "apathy and depression" and
INTRODUCTION
Neuropsychiatric symptoms (NPS) are usually associated with cognitive deficits during the course of Alzheimer's disease (AD) and related disorders. Apathy and depression are the two most frequent NPS in AD [1, 2] , and both have a negative impact on the evolution of the disease [3, 4] and are predictive of early institutionalization.
Marin was the first to present apathy as a disorder of motivation, defined as "the direction, intensity and persistence of goal-directed behaviour" [5] . Most of the current descriptions acknowledge this point and consider apathy in terms of a lack of goal-directed behavior, cognition, or emotion [6] [7] [8] , with lack of interest as one of the core clinical features [9] or as "an absence of responsiveness to stimuli as demonstrated by lack of self initiated action" [10] . Prevalence of apathy in the early stages of dementia is estimated at between 36% and 65% in mild AD [1, 11, 12] and is also frequently reported in the pre-demented stage and in mild cognitive impairment (MCI) with frequency between 15 and 41% in MCI [12] [13] [14] [15] [16] [17] .
Average frequency of depression in mild AD is between 20-50% [12, 18, 19] and is lower in MCI subjects [1, 20] . Apathy and depression syndromes share common symptoms [3, 21] but it has been shown that they have distinct neural pathways as demonstrated by several neuroimaging studies [22] . Additionally, apathy, but not depression, was found to predict progression from amnestic MCI to AD [9, 16, 23] .
The discrepancies between the reported prevalence of apathy and depression in AD and MCI may be related to several methodological issues, such as tool validity, threshold of scores for diagnosis, socio-environmental factors in selected populations, or severity of cognitive deficits. Global and symptomspecific scales have been developed to assess the presence and severity of NPS in dementia. The diversity of available assessment methods testifies the interest in this field but also constitutes a limitation in the comparability of publications and clinical trials. As diagnosis of depression and apathy is most often based on a quantitative assessment (i.e., scores on specific scales), diagnostic criteria for depression [18] and apathy [24] are currently available. Data with application of these qualitative methods is limited [25] .
The main objective of this study is to evaluate the prevalence of apathy and depression, and their interaction, using specific diagnostic criteria among recently diagnosed AD subjects. Secondary objectives are to assess the relationships 1) between both apathy and depression and the impact on patients' dependency, and 2) between both apathy and depression and physical comorbidities.
MATERIALS AND METHODS

Population
A cross-sectional national epidemiological study was conducted by a national representative sample of clinicians. The investigators were private practice neurologists, geriatricians, or psychiatrists working in a memory clinic. They were randomly selected on the basis of their main specialty.
Each clinician had to check for the presence of apathy and depression according to the specific diagnostic criteria in consecutive patients with the following inclusion criteria: people older than 65, Mini Mental Score Examination (MMSE) score higher than 19 [26] , and diagnosis of probable AD according to the NINCDS-ADRDA criteria [27] . The diagnosis had to have been established within the previous 6 months. The study protocol has been approved by the French ethical committee for data management (CNIL). The demographic data recording process was the same as the data recording used in the French National Data Bank for dementia [28] and includes age, gender, education level, and the presence or absence of the French official financial support for elderly people with loss of autonomy (APA). More specifically, the patient or his/her family, in relation with the general practitioner, can apply for APA from the regional health administration in order to partially cover costs related to loss of autonomy (e.g., nurse, home help, home delivered meals, day hospital charges, nursing home charges). The decision on whether to grant this allowance is made after a patient home visit and a fully independent standardized interview with a social worker from the regional administration. Table 1 Diagnostic criteria for depression [18] and apathy [24] Depression Apathy 
Diagnosis and assessment
Depression was diagnosed using the diagnostic criteria for depression in AD [18] , and apathy with the diagnostic criteria for apathy in AD and neuropsychiatric disorders [24] (Table 1) .
Among the diagnostic criteria of apathy, criterion B describes the three core clinical domains of apathy, namely reduced goal-directed behavior, goal-directed cognitive activity, and emotions. Criterion B is based on the premise that change in motivation can be assessed by examining a patient's responsiveness to internal or external stimuli. To be fulfilled, clinical criterion B requires the presence of a minimum of one symptom in at least two of the three domains for a period of at least four weeks and most of the time.
The cognitive, behavioral, and functional assessment included the MMSE and the scale of Instrumental Activities of Daily Living (IADL) [29] detection score. Dependency and loss of autonomy was estimated by the percentage of subjects receiving APA. Physical comorbidity assessment used the Cumulative Illness Rating Scale (CIRS) 5-point Likert scale, measuring degree of severity (ranging from "1 = none" to "5 = extremely") [30] . The CIRS has been used excluding from the list of comorbidities the psychiatric Table 2 Prevalence of depression and apathy symptoms in the overall population Total (n = 734) Depression diagnostic criteria [18] Depressed and behavioral comorbidities, which can overlap with apathy. All these assessments were based on the caregiver's interview and the examination by physician.
Statistical analysis
Statistical analyses were performed using SAS software (v 9.1, SAS Institute, North Carolina). Two-group comparisons for quantitative variables were made using a Student test after verifying the equality of variances (in case of unequal variances, the Satterthwaite approximation method was used). For other group comparisons (>2), quantitative variables were compared using analysis of variance in case of equality of variance (Levène test) and normality of distributions (visual analysis of histograms or the Shapiro-Wilk test). Otherwise, a non-parametric analysis was performed (Kruskal-Wallis test). A 0.05 threshold of significance was implemented. Post hoc analysis used a Bonferroni procedure with a correction for multiple comparisons. For ordinal variables, group comparisons were made using a chi-square test. A 0.05 threshold of significance was chosen for all analyses.
RESULTS
A total of 1,034 patients with mild AD were screened by 115 physicians (75 private practice neurologists and 40 physicians working in a memory clinic). 307 subjects (age = 77.5 ± 7.6 years; M/F = 43/57%; MMSE = 23.2 ± 3.6) were not included in the analysis. The main reasons for non-inclusion were the patient's or accompanying person's refusal to participate in the study (27%) and lack of time for the physician to perform the screening (34.2%). Among the screened patients, 734 AD patients were included (age = 80 ± 6.6 years; M/F = 38/62%; MMSE = 23.1 ± 2.2; range 20-29). Included patients were slightly older than the screened patients (p < 0.001). No difference for these populations was observed for gender (p = 0.15) or for MMSE (p = 0.67). These characteristics are similar to previously described cohorts of AD patients with mild severity [1, 2] . Mean time between AD diagnosis and inclusion was 2.6 ± 5.9 months. 15.4% of the patients received the APA.
According to the specific diagnostic criteria, depression had a 47.9% prevalence, with apathy prevalence at 41.6%. Frequency of Apathy criterion B alone was 54.8%. Table 2 details the most frequent symptoms observed among the diagnostic criteria of apathy and depression. The three most frequent depressive symptoms are fatigue or loss of energy (59.4%), decreased positive affect or pleasure in response to social contacts and activities (46.2%), and psychomotor agitation or retardation (36.9%). Depressed mood was less frequent (24.4%). Concerning apathy, Domain B2 (cognition) is the most frequently altered (63.6%), followed by Domains B1 (action; 60.6%) and B3 (emotion; 43.8%).
Apathy and/or depression according to the diagnostic criteria are present in more than half of patients. The population was divided into four clinical groups: "apathy only", "depression only", "depression and apathy" associated, and "no apathy/no depression". The four subgroups are similar with regard to the prescription of acetylcholinesterase inhibitors and memantine. However, the prescription of antidepressants was significantly higher in the subgroups presenting either solely with depression criteria or criteria of both "apathy and depression". Data for the four subgroups is presented in Table 3 .
Post hoc analysis indicated that the "apathy and depression" subgroup had a significantly lower MMSE score than the "no apathy no depression" subgroup, together with a lower IADL score than the "no apathy no depression" subgroup, the "apathy" subgroup and the "depression "subgroup. We calculated the effect size of the MMSE difference between "apathy and depression" and "no apathy no depression" groups (0.28) and of the MMSE difference between "apathy alone" and "depression alone" (0.39). These effect size values are estimated to be « low » according to Cohen's conventional ranges.
In addition, the "apathy and depression" subgroup had a significantly higher time since diagnosis than the "no apathy no depression" subgroup.
Among the depressive symptoms (depression diagnostic criteria A), depressed mood was only detected in 24% of the patients with depression either alone or associated with apathy. Likewise, decreased positive affect or pleasure in response to social contacts and activities is present in 62.9% of the "depression alone" subgroup and 81.3% of the "apathy and depression" subgroup.
Distribution of comorbidities (excluding dementia and psychiatric domains) is presented in Table 4 . For the whole population, mean comorbidity and severity indexes are mild to moderate (1.3 ± 1.4 for the CIRS, excluding psychiatric and behavioral comorbidities). The most frequent comorbidities are hypertension (59.3%), cardiac (34.7%), endocrine (26.3%), and vascular (20.6%). Post hoc analysis indicated that CIRS was significantly higher for the "apathy and depression" subgroup in comparison to the three other subgroups (p < 0.05). Patients belonging to the "apathy and depression" and "depression alone" groups have more frequent neurological comorbidities (p < 0.001) than the two other subgroups.
DISCUSSION
This study using diagnostic criteria concludes that apathy, either alone or associated with depression, affects 41.8% and depression, alone or associated with apathy, affects 47.8% of a representative sample of patients with mild AD. Concerning apathy, these figures are in the range of previous studies using quantitative scales as Neuropsychiatric Inventory (NPI) or qualitative criteria. In Van Reekum's review on apathy, apathy ranges from 55% to 80% in studies using the NPI and from 37% to 86% in studies using specific apathy scales [31] . In a recent study using the diagnostic criteria of apathy, Mulin et al. [25] found a higher prevalence of apathy in AD subjects (55% versus 41.6% in the present study). The lower percentage might be explained by the low severity of AD in the present sample (MMSE score 23.1 ± 2.2 versus 18.3 ± 4.6).
Concerning depression, Vilalta-Franch et al. [19] found a prevalence of 27.4% when using Olin's criteria (versus 47.9% in our study), and 10.6% when using the DSM-IV criteria in a cohort of AD subjects characterized by a lower mean MMSE score (17.1 ± 4.1). Nevertheless, previous studies using quantitative scales showed that the prevalence of depression in AD increases with the progression of cognitive decline [11, [32] [33] [34] , as other studies found a relative stability or decrease of depression prevalence [35, 36] . In a five-year longitudinal cohort study, prevalence of depression increased during four years of follow-up, then decreased in year 5 [36] . More generally, the use of categorical diagnostic criteria, such as the DSM-IV and the ICD-10, provides lower prevalence of depression compared with the use of specific diagnostic criteria. This consistent finding in literature may be due to the fact that non-specific criteria for depression are more restrictive than Olin's criteria which require only three depressive symptoms or more to diagnose depression in AD, instead of the five or more symptoms required to diagnose major depressive episode [18] .
The high prevalence of the association between apathy and depression raises some concern about the possible overlap between the two syndromes. The present study revealed that more than 56% of patients presenting with apathy or depression have both syndromes. This was shown in previous cohort studies showing that about half of the patients with apathy have depression and vice-versa [1, 37] .
One possible explanation lies at the symptomatic level. In the overall population, results indicated that decreased positive affect in response to social contacts or activities, one of the clinical symptoms of depression criteria, is more frequent than the depressed mood (46.2% versus 24.4%). With the same criteria, the high prevalence of social isolation and withdrawal (39.7%) may account to some overlap with apathy. Likewise, within the diagnostic criteria of apathy, loss of or diminished cognitive activity is the most frequent symptom in the diagnostic criteria (63.6%). As already observed in Parkinson disease, there is a probable overlap between symptoms considered both as apathetic and depressive symptomatology [38] . In fact, loss of directed-goal cognitive activity is usually interpreted [24] as a loss of or diminished interest that is most observed in leisure activities. This domain indicates that the patient is less interested in the activities and plans of others, in friends and family members, or in their own usual leisure activities. This meaning is close to the meaning of the decreased positive affect symptoms of the depression criteria, which is considered as decreased interest or pleasure in things in the DSM IV. The present study confirms that these "overlapping" symptoms are present in 62.9% of the patients presenting the depression criteria alone and in 81.3% of the patients presenting both apathy and depression diagnostic criteria. Due to the cross-sectional design of our study, we could not determine if apathy or depression were present before the onset of dementia and may be risk factors or prodromes. It was also not possible to evaluate the dynamics and interrelation of these symptoms with time.
It also has been hypothesized that depressive symptoms in AD are more often related to vegetative or action disturbances than to negative mood or affective distress, and therefore may be similar to apathy symptoms [3, 39, 40] . This study also indicated that patients with apathy and depression more frequently required a resource allowance for dependency (APA) than patients with only depression or none of these syndromes, even with a small difference in cognitive level between groups. We also demonstrated that the patients with both syndromes have a lower IADL score when compared to other subgroups. This suggests that the association of apathy and depression may be more closely associated with lack of autonomy, as was demonstrated in other studies showing that these patients are more functionally impaired, independently of their cognitive deficit [2, 4, 41] . However, we could not provide any evidence of an association between apathy alone or depression alone and loss of autonomy. This suggests that depression and apathy may have a cumulative negative effect on functional outcomes.
Concerning physical comorbidities, we also observed that a majority of patients in all clinical groups had hypertension. Moreover, apathetic patients with or without depressive symptoms had a higher prevalence of cardiological comorbidities than patients in the other groups. Other studies on diverse elderly populations have found similar results. Longitudinal studies after strokes reported a high prevalence of both apathy and depression symptoms [42] [43] [44] . In dementia, apathy as mental slowness was more frequently associated with vascular white-matter changes [45] . In a community-dwelling elderly subject sample, an association was found between apathy and hypertension and white matter lesions [46] . This relation had been otherwise considered as a depression-executive dysfunction syndrome of late life [47] .
The question of the association between vascular factors and specific depressive symptoms provided conflicting results. In our study, AD subjects having isolated depressive symptoms exhibited less frequently cardiological comorbidities (23.2%). Previous reviews or large cohort studies in the elderly confirmed this relationship between depressive symptoms and cardiovascular risk factors [48, 49] , while others studies did not find a direct relation. In many cases, depressive symptoms may precede cardiovascular comorbidities or share only some of pathophysiological factors [50] . Conversely, depression alone or associated with apathy is more frequently associated with neurological disorders (47.3%). One hypothesis is that neurological disturbances may have more depressive consequences due to the incapacity associated with this group of disorders.
The fact that this study was largely conducted among private sector specialists is a positive point since, in France, these doctors are very often consulted by the public at an early stage. It is also a drawback, as it is more difficult to access para-clinical details leading to the diagnosis or the register of associated treatment. A further limitation with regard to this study stems from the fact that it was conducted at a given time and that there is no data describing developments in these four subgroups. This data is, however, of interest as it provides an overview of the associations between apathy and depression in a significant population.
In conclusion, this study confirms that an accurate qualitative assessment, using diagnostic criteria of depression and apathy, reveals these syndromes both have a high prevalence. They overlap considerably and this may due to the fact that diagnostic criteria shared the same symptoms. When a patient fulfills the two diagnostic criteria, there is a greater need for social support. Neurophysiological studies looking at the relationship with vascular factors will probably be improved by taking this symptomatic overlap into account.
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